Details of the Drug

General Information of Drug (ID: DMMBGH3)

Drug Name

123I-MNI-330

Indication

Disease Entry	ICD 11	Status	REF
Alzheimer disease	8A20	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00657813) Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-amyloid Protein Deposition. U.S. National Institutes of Health.